2Pollock BG, Laghrissi-Thode F, Wagner WR.Evaluation of platelet ac- tivation in depressed patients with ischemic heart disease after paroxe- tine or nortriptyline treatment [ J ]. Clin Psychopharmacol, 2000,20 (6) : 137-140.
3Shimbo D, Davidson KW, Haas DC, et al.Negative impact of depression on Outcomes in patients with coronary artery disease :mechanisms, treatment considerations, and future directions [J ]. International Soci- ety on Thrombosis and Haemostasis, 2004,25 (3) : 897-908.
4Glassman AH,O'Connor CM.Calif RM,et al.Sertraline treatment of major depression in patients with acute MI or unstable angina [J ]. JA- MA.2002,288(6) :701-709.
5Taylor C B, Youngblood M E, Catellier D,et al. Effects of antidepres-sant Medication on morbidity and mortality in depressed patients after myocardial Infarction [J ]. Archives of" General Psychiatry, 2005, 62(7) :792-798.
2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.
1Scalone G,Aurigemma C,Tomai F,et al.Effectof pre-infarction angina on plateletreactivity in acutemyocardial in farction[J].International Journal of Cardiology,2013,167(1):51-56.